Withdrawal of a drug from the market: what should the prescriber do?
UMass Chan Affiliations
Department of Medicine, Division of Geriatric MedicineMeyers Primary Care Institute
Document Type
Letter to the EditorPublication Date
1994-10-26Keywords
Drug ApprovalDrug Utilization
Product Surveillance, Postmarketing
United States
United States Food and Drug Administration
Health Services Research
Medicine and Health Sciences